The U.S. Food and Drug Administration (FDA) has approved a new once-daily pill for certain patients with advanced pancreatic cancer after clinical trial results showed a significant improvement in survival. The newly approved treatment is intended for patients with metastatic pancreatic cancer who have already received treatment or are unable to undergo combination chemotherapy. The…